|
|
863A Mitten Road
Burlingame, CA 94010 USA
phone:(650) 259-1800
fax:(650) 697-8828
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.juvaris.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Vaccines for cancer and infectious diseases. |
|
| Management |
| Grant E. Pickering, President and Chief Executive Officer; John Warner, Ph.D., Co-Founder, Chief Scientific Officer and Vice President of Operations; Thomas P. Monath, M.D., Chief Medical Officer (Acting); Kimberlee Gonzaga, CPA, Chief Financial Officer; Lee B. Bussey, Ph.D., Sr. Vice President, Manufacturing; Jeff Fairman, Ph.D., Co-Founder, Vice President, Research |
| |
|
|
| |
|
| Keywords |
| vaccines, cancer, infectious diseases, cationic lipids, DNA complexes, InfectiousDisease |
|
|
|
| Description |
|
Juvaris BioTherapeutics developts therapeutic vaccines for cancer and infectious diseases using its novel technology platform of cationic lipids and non-coding DNA complexes. |
|
| Technology / Differentiation |
| The Juvaris therapeutic vaccine platform provides immune stimulation of both the innate and adaptive immune responses. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members